Genetic variation in pro-inflammatory cytokines and meningococcal sepsis

Current Opinion in Infectious Diseases

Volumn 23, Issue 3, 2010, Pages 255-258

  Deasy, Alice ^a   Read, Robert C ^a  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

Cytokines; Interleukin 1; Meningococcal disease; Polymorphism; Single nucleotide; Tumour necrosis factor

Indexed keywords

CYTOKINE; INTERLEUKIN 1 RECEPTOR; TUMOR NECROSIS FACTOR;

CYTOKINE PRODUCTION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; INFECTION SENSITIVITY; MENINGOCOCCOSIS; REVIEW; SEPSIS;

CYTOKINES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MENINGOCOCCAL INFECTIONS; POLYMORPHISM, GENETIC; SEPSIS;

EID: 77951585180     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0b013e32833939de     Document Type: Review

References (32)

1. Trotter CL, Chandra M, Cano R, et al. A surveillance network for meningo-coccal disease in Europe. FEMS Microbiol Rev 2007; 31:27-36.
2. Stephens DS, Greenwood B, Brandtzaeg P. Epidemic meningitis, meningo-coccaemia, and Neisseria meningitidis. Lancet 2007; 369:2196-2210.
3. Cartwright KA, Stuart JM, Jones DM, Noah ND. The Stonehouse survey: nasopharyngeal carriage of meningococci and Neisseria lactamica. Epidemiol Infect 1987; 99:591-601.
4. Trotter CL, Gay NJ, Edmunds WJ. The natural history of meningococcal carriage and disease. Epidemiol Infect 2006; 134:556-566.
5. Goldschneider I, Gotschlich EC, Artenstein MS. Human immunity to the meningococcus. I. The role of humoral antibodies. J Exp Med 1969; 129:1307-1326.
6. Darton T, Guiver M, Naylor S, et al. Severity of meningococcal disease · associated with genomic bacterial load. Clin Infect Dis 2009; 48:587-594.
7. Cinel I, Opal SM. Molecular biology of inflammation and sepsis: a primer. Crit Care Med 2009; 37:291-304.
8. Waage A, Halstensen A, Espevik T. Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1987; 1:355-357.
9. Waage A, Brandtzaeg P, Halstensen A, et al. The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. J Exp Med 1989; 169:333-338.
10. Nielsen EW, Hellerud BC, Thorgersen EB, et al. A new dynamic porcine model of meningococcal shock. Shock 2009; 32:302-309.
11. Haralambous E, Weiss HA, Radalowicz A, et al. Sibling familial risk ratio of meningococcal disease in UK Caucasians. Epidemiol Infect 2003; 130:413-418.
12. Westendorp RG, Langermans JA, Huizinga TW, et al. Genetic influence on cytokine production and fatal meningococcal disease. Lancet 1997; 349:1 70-173.
13. Sprong T, van der Ven-Jongekrijg J, Neeleman C, et al. Influence of innate cytokine production capacity on clinical manifestation and severity of pediatric meningococcal disease. Crit Care Med 2009; 37:2812-2818.
14. Brouwer MC, deGans J, Heckenberg SG, et al. Host genetic susceptibility to pneumococcal and meningococcal disease: a systematic review and metaanalysis. Lancet Infect Dis 2009; 9:31-44.
15. van der Linden MW, Huizinga TW, Stoeken DJ, et al. Determination of tumour necrosis factor-alpha and interleukin-10 production in a whole blood stimula tion system: assessment of laboratory error and individual variation. J Immunol Methods 1998; 218 (1-2):63-71.
16. Bayley JP, Ottenhoff TH, Verweij CL. Is there a future for TNF promoter polymorphisms? Genes Immun 2004; 5:315-329.
17. Wilson AG, de Vries N, Pociot F, et al. An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med 1993; 177:557-560.
18. Wilson AG, Symons JA, McDowell TL, et al. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 1997; 94:3195-3199.
19. Mira JP, Cariou A, Grall F, et al. Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. J Am Med Assoc 1999; 282:561-568.
20. Nadel S, Newport MJ, Booy R, Levin M. Variation in the tumor necrosis factor-alpha gene promoter region may be associated with death from meningococcal disease. J Infect Dis 1996; 174:878-880.
21. Read RC, Camp NJ, di Giovine FS, et al. An interleukin-1 genotype is associated with fatal outcome of meningococcal disease. J Infect Dis 2000; 182:1557-1560.
22. Mewar D, Marinou I, Lee ME, et al. Haplotype-specific gene expression profiles in a telomeric major histocompatibility complex gene cluster and susceptibility to autoimmune diseases. Genes Immun 2006; 7:625-631.
23. Read RC, Teare DM, Pridmore AC, et al. The tumor necrosis factor poly-morphism TNF (\308) is associated with susceptibility to meningococcal sepsis, but not with lethality. Crit Care Med 2009; 37:1237-1243.
24. van Deuren M, van der Ven-Jongekrijg J, Vannier E, et al. The pattern of interleukin-1beta (IL-1beta) and its modulating agents IL-1 receptor antago nist and IL-1 soluble receptor type II in acute meningococcal infections. Blood 1997; 90:1101-1108.
25. Dinarello CA. Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 2009; 27:519-550.
26. Goldbach-Mansky R, Kastner DL. Autoinflammation:the prominent role of IL-1 in monogenic autoinflammatory diseases and implications for common ill nesses. J Allergy Clin Immunol 2009; 124:1141-1149.
27. di Giovine FS, Takhsh E, Blakemore AI, Duff GW. Single base polymorphism at\511 in the human interleukin-1 beta gene (IL1 beta). Hum Mol Genet 1992; 1:450.
28. Cox A, Camp NJ, Nicklin M, et al. An analysis of linkage disequilibrium in the interleukin-1 gene cluster, using a novel grouping method for multiallelic markers. Am J Hum Genet 1998; 62:1180-1188.
29. Read RC, Cannings C, Naylor SC, et al. Variation within genes encoding interleukin-1 and the interleukin-1 receptor antagonist influence the severity of meningococcal disease. Ann Intern Med 2003; 138:534-541.
30. Montero JM, Prieto RG, Alejandre CG, et al. Hospital admissions for meningococcal infection in Spain (1997-2005). J Infect 2009; 58:15-20.
31. von Gottberg A, du Plessis M, Cohen C, et al. Emergence of endemic serogroup W135 meningococcal disease associated with a high mortality rate in South Africa. Clin Infect Dis 2008; 46:377-386.
32. Koster-Rasmussen R, Korshin A, Meyer CN. Antibiotic treatment delay and outcome in acute bacterial meningitis. J Infect 2008; 57:449-454.